Pharmstandard International S.A., 10% Owner at ARGOS THERAPEUTICS INC (ARGS), bought 53,524 shares at $4.23 ($226K) on 2016-08-19, disclosed to the SEC on 2016-08-23.
Open-market purchase of $226k ARGS by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| ARGS | BUY | 2016-09-07 | $162K | — | Filing → |
| ARGS | BUY | 2016-08-29 | $252K | — | Filing → |
| ARGS | BUY | 2016-08-29 | $252K | — | Filing → |